Serum DcR2 has been proposed as a prognostic marker in prostate cancer [14], and urinary DcR2 (uDcR2) levels have been positively correlated with renal fibrosis in CKD [15, 16]. Here, TNFRSF10D is linked to prostate carcinoma.